InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Bormann-Kennedy Barbara-Jean Anne, 董事. Officer active across 1 company, notably Xeris Biopharma Holdings, Inc.. In total, 5 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €84k. Activity tracked since 8 June 2022. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Barbara-Jean Anne Bormann-Kennedy is a Director at Xeris Biopharma Holdings, Inc. She plays a vital role in corporate governance and strategic decision-making. As a board member, she helps guide Xeris Biopharma's growth initiatives. Her experience in the biopharmaceutical sector is an asset for the company.